Sample toxicity testing is a critical safety evaluation process used to determine whether materials, chemicals, and consumer products pose harmful biological risks to humans, animals, or the environment. By applying internationally recognized standards such as ISO 10993, OECD test guidelines, and GB/T 16886, accredited third-party laboratories assess acute toxicity, cytotoxicity, irritation, sensitization, and genotoxicity across a wide range of sample types. This technical guide explains the core principles, sample categories, test items, analytical methods, and regulatory applications of sample toxicity testing.
Technical Overview
Sample toxicity testing refers to the systematic laboratory evaluation of a material, extract, or finished product to identify and characterize its potential hazardous effects on biological systems. The fundamental objective is hazard identification and dose–response characterization, which together form the scientific basis for risk assessment and regulatory classification. Toxicity data determine whether a substance or product can safely contact human tissue, be ingested, be inhaled, be applied to skin, or be released into the environment.
Modern toxicity testing is built on a tiered and weight-of-evidence framework. Testing typically begins with in vitro screening methods—such as cytotoxicity assays and bacterial reverse mutation tests—before progressing, only when necessary, to in vivo studies. This approach aligns with the internationally accepted "3Rs" principle (Replacement, Reduction, and Refinement), which encourages the use of non-animal alternatives wherever scientifically valid. Test programs are designed according to the intended use, contact duration, and exposure route of the product under evaluation, following frameworks such as the ISO 10993 series for medical devices, OECD test guidelines for chemicals, and regional regulations including REACH and the GHS classification system.
For solid materials and finished devices, toxicity is frequently evaluated indirectly through extractables and leachables: the sample is extracted under standardized conditions in polar and non-polar solvents, and the resulting extracts are then subjected to biological testing. This allows laboratories to detect migratable toxic substances that would not be revealed by chemical composition analysis alone.
Testing Samples
Medical Devices and Biomaterials
Medical devices ranging from catheters, implants, and syringes to wound dressings, dental materials, and infusion sets require biocompatibility evaluation under the ISO 10993 series and its Chinese counterpart GB/T 16886. The required test battery depends on the nature of body contact (surface, external communicating, or implant) and contact duration (limited, prolonged, or permanent). Typical evaluations include cytotoxicity, sensitization, irritation, systemic toxicity, and genotoxicity of device extracts.
Chemicals and Industrial Materials
Raw chemicals, intermediates, nanomaterials, coatings, adhesives, and polymer additives are tested under OECD test guidelines to support registration, hazard classification, and transport regulations. Endpoints commonly include acute oral, dermal, and inhalation toxicity, along with corrosivity, sensitization, and environmental hazard classification under GHS/CLP criteria.
Cosmetics and Personal Care Products
Finished cosmetics, ingredients, and herbal extracts are assessed for skin irritation, eye irritation, skin sensitization, phototoxicity, and mutagenicity. In regions such as the European Union, animal testing for cosmetics is prohibited, so safety evaluation relies heavily on validated in vitro methods and read-across from existing data.
Food Contact Materials
Plastics, paper, metals, coatings, and adhesives intended for food contact are tested to confirm that migratable substances do not present toxicological concern. Overall migration studies are complemented by toxicological evaluation of specific migrants in accordance with food-contact frameworks such as GB 4806 series standards and applicable EU and FDA reference frameworks.
Toys and Children's Products
Toys are evaluated for the migration of hazardous elements and the presence of toxic substances in line with EN 71, ISO 8124, and ASTM F963. Emphasis is placed on elements such as lead, cadmium, and mercury, as well as on allergenic fragrances, certain phthalate plasticizers, and primary aromatic amines in accessible components.
Environmental and Water Samples
Effluents, surface waters, sediments, and soils are examined using ecotoxicity assays with algae, daphnids, and fish to determine whether discharged substances harm aquatic ecosystems. Results support environmental permitting, hazard classification, and monitoring programs.
Testing Items
Toxicity test items are selected based on exposure scenario and regulatory requirements. The most commonly requested categories include:
- Acute toxicity: oral (LD50), dermal (LD50), and inhalation (LC50) studies that characterize effects following single exposure.
- Repeated-dose toxicity: subacute (28-day) and subchronic (90-day) studies that reveal target-organ effects from cumulative exposure.
- Cytotoxicity: measurement of cell viability and growth inhibition, typically the mandatory first step in biocompatibility screening.
- Skin and eye irritation or corrosion: evaluation of reversible inflammatory or irreversible tissue-damaging effects.
- Skin sensitization: identification of substances that induce delayed-type allergic responses.
- Genotoxicity and mutagenicity: detection of DNA damage, gene mutation, and chromosomal effects.
- Hemocompatibility: assessment of hemolysis, thrombogenicity, and complement activation for blood-contacting devices.
- Pyrogenicity: determination of fever-inducing contaminants, including endotoxin measurement by LAL methods.
- Reproductive and developmental toxicity: evaluation of effects on fertility, embryonic development, and offspring.
- Chronic toxicity and carcinogenicity: long-term studies generally reserved for substances with significant human exposure.
- Ecotoxicity: aquatic and terrestrial hazard assessment using algae, invertebrates, fish, and microorganisms.
Testing Methods
Sample Preparation and Extraction
For materials that cannot be tested directly, extraction is performed according to ISO 10993-12 or ASTM F619. Samples are incubated in polar media (such as saline or culture medium) and non-polar media (such as sesame oil) under controlled temperature and time conditions that simulate or exaggerate clinical or use-phase exposure. The ratio of sample surface area or mass to extraction vehicle is strictly standardized to ensure reproducibility.
Acute Toxicity Testing
Acute systemic toxicity is assessed using OECD test guidelines, including the fixed-dose procedure (TG 420), the acute toxic class method (TG 423), and the up-and-down procedure (TG 425). These modern methods determine hazard classification using few or no deaths as an endpoint, substantially reducing animal use compared with classical LD50 protocols. For medical device extracts, acute systemic toxicity is performed per ISO 10993-11.
In Vitro Cytotoxicity
The MTT viability assay specified in ISO 10993-5 quantifies metabolic activity of exposed cells, with viability below 70% indicating a cytotoxic effect. Complementary formats include the extract (elution) test, direct contact test, and agar diffusion test, performed using established mammalian cell lines such as L929 fibroblasts.
Genotoxicity Testing
The standard battery combines the bacterial reverse mutation (Ames) test (OECD TG 471, ISO 10993-3) with the in vitro mammalian chromosomal aberration test (OECD TG 473) or micronucleus assay (OECD TG 487). Positive or ambiguous in vitro findings may trigger follow-up in vivo testing under a weight-of-evidence strategy.
Irritation and Sensitization Methods
Skin irritation is evaluated using reconstructed human epidermis (RhE) models under OECD TG 439, while eye hazard identification uses the bovine corneal opacity test (TG 437), the isolated chicken eye test (TG 438), or the EpiOcular/EIT method (TG 492). Skin sensitization can be addressed through the local lymph node assay (TG 429), the DPRA and KeratinoSens in vitro methods (TG 442 series), or guinea pig maximization protocols where in vivo confirmation is required.
Ecotoxicity Methods
Aquatic hazard assessment applies the algal growth inhibition test (OECD TG 201), the Daphnia magna immobilization test (OECD TG 202), and the fish acute toxicity test (OECD TG 203). Biodegradability testing (OECD TG 301 series) and bioaccumulation studies complete the environmental profile for substance registration.
Applications
Sample toxicity testing results directly support product registration, market access, and occupational and environmental safety programs. Key application scenarios include:
- Medical device regulatory submission, where a complete ISO 10993 biological evaluation report is required for registration and listing in major markets.
- Chemical substance registration under regulations such as REACH, where base-set toxicity data are mandatory for tonnage-banded submissions.
- Hazard classification and labeling of substances and mixtures under GHS, including transport classifications for corrosive and acutely toxic materials.
- Safety substantiation of cosmetics and consumer products under regional cosmetic regulations and general product safety directives.
- Compliance verification for toys and childcare articles against EN 71, ISO 8124, and ASTM F963 requirements.
- Supplier qualification, incoming material control, and change management within quality management systems certified to ISO 9001 or ISO 13485.
- Investigation of product recalls, failure analysis, and litigation support where toxicological causation must be established.
- Environmental risk assessment for effluent discharge permits and contaminated site evaluation.
FAQ
How much sample is required for toxicity testing?
Sample requirements vary significantly by test item. An in vitro cytotoxicity assay may require a few grams or a few square centimeters of material, while acute systemic or subchronic studies require substantially larger quantities. Extraction-based tests are calculated according to the standardized surface-area-to-volume or mass-to-volume ratios defined in ISO 10993-12.
Are animal tests always necessary?
No. Regulatory frameworks increasingly accept validated in vitro alternatives, and a chemical or material with sufficient existing data may qualify for read-across or waiving. Test strategies should be justified in a documented biological evaluation plan to avoid unnecessary animal use in line with the 3Rs principle.
How long does toxicity testing take?
Simple in vitro assays such as cytotoxicity typically complete within one to three weeks. Genotoxicity batteries generally require four to eight weeks, while subchronic in vivo studies with recovery periods may extend to several months. Accredited third-party laboratories can provide project-specific timelines after reviewing the test plan.
What is the difference between cytotoxicity and systemic toxicity?
Cytotoxicity describes localized harm to cells observed in culture, providing a rapid screening signal. Systemic toxicity evaluates effects on the whole organism—such as the liver, kidney, or nervous system—after the substance or extract is absorbed and distributed through the body. Both endpoints may be required depending on the product's contact nature and duration.
Which standards govern medical device toxicity testing in different markets?
The ISO 10993 series is harmonized internationally, and GB/T 16886 is the corresponding Chinese national adoption. Regions such as the United States and Europe reference these standards within their respective device regulatory frameworks, so a well-designed test program to ISO 10993 generally supports submissions across multiple jurisdictions.
Can toxicity testing replace chemical analysis?
Not entirely. Chemical analysis identifies and quantifies specific hazardous substances, whereas toxicity testing measures the integrated biological effect of a sample or its extracts. The two approaches are complementary, and modern safety evaluations combine both, often supported by toxicological risk assessment of identified extractables and leachables.